Structure of Ivacaftor
CAS No.: 873054-44-5
*Storage: {[sel_prStorage]}
*Shipping: {[sel_prShipping]}
The BI-3802 was designed by Boehringer Ingelheim and could be obtained free of charge through the Boehringer Ingelheim open innovation portal opnMe.com, associated with its negative control.
Ivacaftor is a potentiator of CFTR targeting G551D-CFTR and F508del-CFTR with EC50 of 100 nM and 25 nM, respectively.
Synonyms: VX-770
4.5
*For Research Use Only !
Change View
Size | Price | VIP Price | US Stock |
Global Stock |
In Stock | ||
{[ item.pr_size ]} |
Inquiry
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,1,item.pr_is_large_size_no_price, item.discount_usd) ]} {[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]} |
Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]} | Inquiry {[ item.pr_usastock ]} In Stock Inquiry - | {[ item.pr_chinastock ]} {[ item.pr_remark ]} In Stock 1-2 weeks - Inquiry - | Login | - + | Inquiry |
Please Login or Create an Account to: See VIP prices and availability
US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days
1-2weeks
Inquiry
{[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
{[ getRatePrice(item.pr_usd,1,item.mem_rate,item.pr_is_large_size_no_price, item.pr_usd) ]}
Inquiry
{[ getRatePrice(item.pr_usd,item.pr_rate,1,item.pr_is_large_size_no_price, item.vip_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
In Stock
- +
Please Login or Create an Account to: See VIP prices and availability
US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
CAS No. : | 873054-44-5 |
Formula : | C24H28N2O3 |
M.W : | 392.49 |
SMILES Code : | O=C(C1=CNC2=C(C=CC=C2)C1=O)NC3=CC(O)=C(C(C)(C)C)C=C3C(C)(C)C |
Synonyms : |
VX-770
|
MDL No. : | MFCD17171361 |
InChI Key : | PURKAOJPTOLRMP-UHFFFAOYSA-N |
Pubchem ID : | 16220172 |
GHS Pictogram: |
![]() |
Signal Word: | Warning |
Hazard Statements: | H302-H315-H319-H335 |
Precautionary Statements: | P261-P305+P351+P338 |
In Vitro:
Concentration | Treated Time | Description | References |
human corneal epithelial cells (pHCECs) | 10 µM | 72 h | To evaluate the effect of Ivacaftor on EXOA-induced P38 phosphorylation and cell death in CF cells, results showed that Ivacaftor significantly reduced P38 phosphorylation and decreased EXOA-induced cell death in CF cells. | PMC10465324 |
human nasal epithelial cells (pHNECs) | 10 µM | 72 h | To evaluate the effect of Ivacaftor on EXOA-induced P38 phosphorylation and cell death in CF cells, results showed that Ivacaftor significantly reduced P38 phosphorylation and decreased EXOA-induced cell death in CF cells. | PMC10465324 |
FRT cells | 10 µM | 48 h | To evaluate the effect of SRI-37240 on CFTR-dependent chloride conductance, results showed that SRI-37240 significantly increased CFTR-dependent chloride conductance and had synergistic effects with G418 | PMC8285393 |
16HBEge cells | 5 µM | 72 h | To evaluate the effect of SRI-41315 on CFTR function, results showed that SRI-41315 significantly increased CFTR function and had synergistic effects with G418 | PMC8285393 |
Calu-3 2B4 cells | 5 µM | 48 h | To evaluate the effect of Ivacaftor on SARS-CoV-2 replication, results showed that Ivacaftor treatment significantly reduced virus titers. | PMC9973274 |
In Vivo:
Administration | Dosage | Frequency | Description | References |
Mice | K18-hACE2 mice | Intraperitoneal injection | 6 mg/kg | Once daily for 8 days | To evaluate the protective effect of Ivacaftor in SARS-CoV-2 infected mice, results showed that Ivacaftor treatment significantly improved survival and reduced lung edema. | PMC9973274 |
Mice | BALB/CJ mice | Subcutaneous injection | 50 mg/kg | Single injection, lasting 28 days | To study the pharmacokinetics of Ivacaftor-loaded PLGA microparticles in mice, the results showed that the microparticle formulation maintained stable plasma drug concentrations for 28 days, with a 6-fold increase in AUC compared to intravenous administration of solubilized Ivacaftor. | PMC10843602 |
Clinical Trial:
NCT Number | Conditions | Phases | Recruitment | Completion Date | Locations |
NCT03525548 | Cystic Fibrosis | Phase 3 | Active, not recruiting | March 2019 | - |
NCT03447249 | Cystic Fibrosis | Phase 3 | Active, not recruiting | April 16, 2019 | - |
NCT03525574 | Cystic Fibrosis | Phase 3 | Enrolling by invitation | June 2021 | - |
NCT03506061 | Cystic Fibrosis | Phase 2 | Not yet recruiting | May 2023 | United States, Alabama ... More >> University of Alabama Cystic Fibrosis Research Center Not yet recruiting Birmingham, Alabama, United States, 35233 Contact: George Soloman, MD 205-975-9776 msolomon@uab.edu United States, Georgia Emory Children's Center Not yet recruiting Atlanta, Georgia, United States, 30322 Contact: Eric Sorscher, MD 205-612-1327 esorscher@emory.edu Less << |
NCT03447262 | Cystic Fibrosis | Phase 3 | Enrolling by invitation | April 24, 2021 | - |
NCT03587961 | Cystic Fibrosis | Early Phase 1 | Not yet recruiting | January 1, 2021 | United States, Alabama ... More >> University of Alabama at Birmingham Birmingham, Alabama, United States, 35233 Less << |
NCT02951182 | Cystic Fibrosis | Phase 2 | Completed | - | - |
NCT02392702 | Healthy | Phase 1 | Completed | - | Australia, South Australia ... More >> CMAX Adelaide, South Australia, Australia, 5000 Less << |
NCT02599792 | Healthy | Phase 1 | Completed | - | Australia, South Australia ... More >> Adelaide, South Australia, Australia, 5000 Less << |
NCT03445793 | - | Recruiting | December 31, 2019 | United States, Colorado ... More >> National Jewish Heatlh Recruiting Denver, Colorado, United States, 80206 Contact: Terri Herrud, BS 303-398-1453 herrudt@njhealth.org Less << | |
NCT02997020 | - | Recruiting | May 2022 | United States, Alabama ... More >> University of Alabama at Birmingham Recruiting Birmingham, Alabama, United States, 35294 Contact: Lisa Clemons, RN, MSN 205-934-9714 lkclemons@uabmc.edu Less << | |
NCT02589236 | Cystic Fibrosis | Phase 2 | Completed | - | - |
NCT02311140 | - | Unknown | January 2018 | Germany ... More >> Jena University Hospital, CF Center Recruiting Jena, Germany, 07743 Contact: Jochen G Mainz, MD, PD +493641938425 jochen.mainz@med.uni-jena.de Less << | |
NCT02722057 | - | Active, not recruiting | December 2019 | - | |
NCT01549314 | - | Active, not recruiting | December 2018 | United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Less << | |
NCT02871778 | Primary Ciliary Dyskinesia | Phase 2 | Active, not recruiting | April 2019 | - |
NCT03045523 | Cystic Fibrosis | Phase 2 | Completed | - | Australia ... More >> The Prince Charles Hospital Chermside, Australia The Alfred Melbourne, Australia Sir Charles Gairdner Hospital Nedlands, Australia Westmead Hospital Westmead, Australia Belgium UZ Brussel Brussels, Belgium UZ Gent Ghent, Belgium UZ Leuven Leuven, Belgium Czechia Fakultni nemocnice v Motole Praha, Czechia Germany Universitaetsklinikum Carl Gustav Carus TU Dresden Dresden, Germany Universitätsklinikum Erlangen Erlangen, Germany University Children´s Hospital Tübingen, Germany Ireland Cork University Hospital Cork, Ireland Beaumont Hospital Dublin, Ireland St Vincents University Hospital Dublin, Ireland United Kingdom Birmingham Heartlands Birmingham, United Kingdom Royal Devon and Exeter Exeter, United Kingdom St James's University Leeds, United Kingdom Liverpool Heart and Chest Hospital Liverpool, United Kingdom Royal Brompton Hospital London, United Kingdom University Hospital of South Manchester Manchester, United Kingdom Royal Victoria Infirmary Newcastle, United Kingdom Southampton General Hospital Southampton, United Kingdom Less << |
NCT03537651 | Cystic Fibrosis | Phase 3 | Enrolling by invitation | December 2020 | - |
NCT02445053 | - | Active, not recruiting | December 2020 | Italy ... More >> Bari, Italy Messina, Italy Milano, Italy Milan, Italy Naples, Italy Potenza, Italy Verona, Italy Netherlands Den Haag, South Holland, Netherlands Amsterdam, Netherlands Gronningen, Netherlands Heidelberglaan, Netherlands Nijmegen, Netherlands Rotterdam, Netherlands United Kingdom London, Greater London, United Kingdom Birmingham, West Midlands, United Kingdom Less << | |
NCT02347657 | Cystic Fibrosis | Phase 3 | Completed | - | - |
NCT03559062 | Cystic Fibrosis | Phase 3 | Recruiting | February 2019 | Australia ... More >> Hunter Medical Research Institute (HMRI) Recruiting New Lambton Heights, Australia Princess Margaret Hospital for Children Recruiting Perth, Australia Lady Cilento Children's Hospital Recruiting South Brisbane, Australia The Children's Hospital at Westmead Recruiting Westmead, Australia Belgium Universitair Ziekenhuis Brussel - Campus Jette Recruiting Brussels, Belgium Universitaire Ziekenhuizen Leuven - Campus Gasthuisberg Recruiting Leuven, Belgium Denmark University of Copenhagen Rigshospitalet Recruiting Copenhagen, Denmark France Groupe Hospitalier Pellegrin - Hôpital des Enfants Recruiting Bordeaux Cedex, France Hôpital Necker - Enfants Malades Recruiting Paris, France Germany Universitaetsklinikum Essen Recruiting Essen, Germany Klinikum der Johann Wolfgang Goethe-Universitaet Recruiting Frankfurt, Germany Universitaetsklinikum Giessen und Marburg GmbH Standort Giessen Recruiting Giessen, Germany Medizinische Hochschule Hannover Recruiting Hannover, Germany Universitaetsklinikum Heidelberg Recruiting Heidelberg, Germany Universitaetsklinikum Jena Recruiting Jena, Germany Universitaetsklinikum Koeln Not yet recruiting Koeln, Germany Universitaetsklinikum Tuebingen Recruiting Tuebingen, Germany Ireland Our Lady's Children's Hospital Recruiting Dublin, Ireland University Hospital Limerick Recruiting Limerick, Ireland Poland Klinika Mukowiscydozy, Oddział Chorób Płuc SZP ZOZ Recruiting Dziekanow Lesny, Poland Switzerland Inselspital - Universitaetsspital Bern Recruiting Bern, Switzerland Kinderspital Zuerich Recruiting Zuerich, Switzerland United Kingdom Royal Hospital for Sick Children Recruiting Edinburgh, United Kingdom Leeds General Infirmary Recruiting Leeds, United Kingdom Royal Brompton Hospital Recruiting London, United Kingdom Nottingham University Hospital City Campus Recruiting Nottingham, United Kingdom Southampton General Hospital Recruiting Southampton, United Kingdom Less << |
NCT01381289 | Cystic Fibrosis | APPROVED_FOR_MARKETING | - | - | |
NCT03256968 | Cystic Fibrosis | Phase 4 | Active, not recruiting | December 31, 2018 | United States, Alabama ... More >> University of Alabama at Birmingham Birmingham, Alabama, United States, 35233 Less << |
NCT02724527 | Cystic Fibrosis | Phase 2 | Unknown | April 2017 | United States, Colorado ... More >> National Jewish Health Denver, Colorado, United States, 80206 United States, Maryland Johns Hopkins Hospital Baltimore, Maryland, United States, 21287 United States, Massachusetts Boston Children's Hospital Boston, Massachusetts, United States, 02115 United States, Missouri Washington University St. Louis, Missouri, United States, 63110 United States, New York Columbia University New York, New York, United States, 10032 United States, Ohio Cincinnati Children's Hospital Cincinnati, Ohio, United States, 45229 Rainbow Babies and Children's Hospital - Case Medical Center Cleveland, Ohio, United States, 44106 Nationwide Children's Hospital Columbus, Ohio, United States, 43205 United States, Oregon Oregon Health and Science University Portland, Oregon, United States, 97239 United States, Pennsylvania Children's Hospital Pittsburgh Pittsburgh, Pennsylvania, United States, 15224 United States, Utah University of Utah Salt Lake City, Utah, United States, 84132 United States, Wisconsin Medical Center of Wisconsin Madison, Wisconsin, United States, 53792 Less << |
NCT03624101 | Cystic Fibrosis | Early Phase 1 | Recruiting | November 1, 2021 | United States, Alabama ... More >> University of Alabama at Birmingham Recruiting Birmingham, Alabama, United States, 35233 Contact: Heather R Hathorne, MAE, RRT 205-939-9568 hhathorne@peds.uab.edu Principal Investigator: Steven M Rowe, MD, MpH Less << |
NCT02875366 | Cystic Fibrosis | Phase 4 | Completed | - | Australia, Victoria ... More >> Melbourne, Victoria, Australia Parkville, Victoria, Australia Australia Adelaide, Australia Camperdown, Australia Clayton, Australia Nedlands, Australia New Lambton Heights, Australia Randwick, Australia South Brisbane, Australia Subiaco, Australia Westmead, Australia United Kingdom Edinburgh, United Kingdom Less << |
NCT02347657 | - | Completed | - | - | |
NCT03061331 | - | Completed | - | - | |
NCT03061331 | Cystic Fibrosis | Phase 2 | Completed | - | Netherlands ... More >> HagaZiekenhuis Den Haag, Netherlands University Medical Center, Utrecht, Department of Pulmonology and Tuberculosis Heidelberglaan, Netherlands Less << |
NCT02141464 | - | Completed | - | United States, Pennsylvania ... More >> Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States, 19104 Less << | |
NCT02070744 | Cystic Fibrosis | Phase 2 | Completed | - | - |
NCT00966602 | Cystic Fibrosis | Phase 1 | Completed | - | Netherlands ... More >> Zuidlaren, Netherlands Less << |
NCT03390985 | - | Completed | - | - | |
NCT02070744 | - | Completed | - | - | |
NCT03278314 | - | - | - | - | |
NCT01216046 | Cystic Fibrosis | Phase 1 | Completed | - | United States, Kansas ... More >> PRA Lenexa, Kansas, United States, 66219 Less << |
NCT01225211 | Cystic Fibrosis | Phase 2 | Completed | - | - |
NCT01208285 | In Development for Cystic Fibr... More >>osis Less << | PHASE1 | COMPLETED | 2025-12-10 | Hradec Králové, Czech Republic... More >>|Praha, Czech Republic|Bratislava, Slovakia Less << |
NCT01910415 | Cystic Fibrosis | Phase 1 | Completed | - | Netherlands ... More >> Zuidlaren, Netherlands Less << |
NCT01060566 | Cystic Fibrosis | Phase 1 | Completed | - | United States, Florida ... More >> Covan CRU, Inc. Daytona Beach, Florida, United States, 32117 Less << |
NCT02039986 | - | Completed | - | United States, Pennsylvania ... More >> The Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States, 19104 Less << | |
NCT01531673 | Cystic Fibrosis | Phase 2 | Completed | - | - |
NCT03601637 | Cystic Fibrosis | Phase 3 | Recruiting | September 2020 | United States, Alabama ... More >> University of Alabama at Birmingham Recruiting Birmingham, Alabama, United States, 35294 United States, Arkansas Arkansas Children's Hospital Recruiting Little Rock, Arkansas, United States, 72202 United States, Illinois Ann & Robert Lurie Children's Hospital of Chicago Recruiting Chicago, Illinois, United States, 60611 United States, Indiana Riley Hospital for Children at Indiana University Health Recruiting Indianapolis, Indiana, United States, 46202 United States, Massachusetts Boston Children's Hospital Recruiting Boston, Massachusetts, United States, 02115 United States, Minnesota Children's Respiratory and Critical Care Specialists, P.A., Children's Hospitals and Clinics of Minnesota Recruiting Minneapolis, Minnesota, United States, 55404 United States, Missouri The Children's Mercy Hospital Recruiting Kansas City, Missouri, United States, 64108 United States, New York Albany Medical College Recruiting Albany, New York, United States, 12208 United States, Pennsylvania Children's Hospital of Philadelphia Recruiting Philadelphia, Pennsylvania, United States, 19104 United States, Texas Cook Children's Medical Center Recruiting Fort Worth, Texas, United States, 76104 United States, Utah University of Utah / Primary Children's Medical Center Recruiting Salt Lake City, Utah, United States, 84132 United States, Washington Seattle Children's Hospital Recruiting Seattle, Washington, United States, 98105 United States, Wisconsin University of Wisconsin Hospital and Clinics Recruiting Madison, Wisconsin, United States, 53792 Canada British Columbia's Children's Hospital Recruiting Vancouver, Canada Less << |
NCT01262352 | Cystic Fibrosis | Phase 2 | Completed | - | United States, California ... More >> Stanford, California, United States United States, Iowa Iowa City, Iowa, United States United States, North Carolina Durham, North Carolina, United States United States, Pennsylvania Pittsburgh, Pennsylvania, United States Canada, Ontario Toronto, Ontario, Canada United Kingdom Belfast, United Kingdom Edinburgh, United Kingdom London, United Kingdom Less << |
NCT01153542 | In Development for Cystic Fibr... More >>osis Less << | Phase 1 | Completed | - | United States, Florida ... More >> Covance CRU, Inc. Daytona Beach, Florida, United States, 32117 Less << |
NCT01262352 | - | Completed | - | - | |
NCT01018368 | Cystic Fibrosis | Phase 1 | Completed | - | United States, Florida ... More >> Daytona Beach, Florida, United States Less << |
NCT03625466 | Cystic Fibrosis | Phase 2 | Recruiting | May 2021 | Germany ... More >> Charite Paediatric Pulmonology Department Recruiting Berlin, Germany Justus-Leibig-Universitat Zentrum fur Kinderheilkunde und Jugendmedizin Recruiting Giessen, Germany Hannover Medical School Recruiting Hannover, Germany Heidelberg Cystic Fibrosis Center Recruiting Heidelberg, Germany Universitatsklinikum Schleswig-Holstein, Klinik für Kinder- und Jugendmedizin Recruiting Lubeck, Germany Less << |
NCT01225211 | - | Completed | - | - | |
NCT03486236 | Cystic Fibrosis | Phase 1 | Completed | - | United Kingdom ... More >> The Medicines Evaluation Unit Manchester, United Kingdom Less << |
NCT03125395 | Cystic Fibrosis | Phase 3 | Active, not recruiting | July 26, 2019 | - |
NCT03150719 | Cystic Fibrosis | Phase 3 | Completed | - | - |
NCT02797132 | - | Completed | - | - | |
NCT03565692 | - | Recruiting | March 1, 2020 | France ... More >> CHU de Bordeaux - CRCM Recruiting Bordeaux, France, 33000 Contact: Mickael FAYON, MD,PhD mickael.fayon@chu-bordeaux.fr Principal Investigator: Mickael FAYON, MD,PhD Sub-Investigator: Patrick BERGER, MD,PhD Sub-Investigator: Raphael ENAUD, MD Centre Hospitalier Universitaire Grenoble Alpes Recruiting Grenoble, France, 38000 Contact: Catherine Llerena, MD CLlerena@chu-grenoble.fr Principal Investigator: Catherine Llerena, MD Sub-Investigator: Boubou Camara, MD CHRU de Lille Not yet recruiting Lille, France, 69000 Contact: Nathalie Wizla, MD nathalie.wizla@chru-lille.fr Principal Investigator: Nathalie Wizla, MD Sub-Investigator: Anne Prévotat, MD Hospices Civils de Lyon Not yet recruiting Lyon, France, 69000 Contact: Philippe Reix, MD philippe.reix@chu-lyon.fr Principal Investigator: Philippe Reix, MD Assistance publique Hôpitaux Marseille Recruiting Marseille, France, 13000 Contact: Jean Christophe Dubus, MD,PhD JeanChristophe.DUBUS@ap-hm.fr Principal Investigator: Jean Christophe Dubus, MD,PhD Assistance Publique Hôpitaux de paris Recruiting Paris, France, 75000 Contact: Harriet Corvol, MD,PhD harriet.corvol@aphp.fr Principal Investigator: Harriet Corvol, MD,PhD Sub-Investigator: Pierre-Regis BURGEL, MD Sub-Investigator: Isabelle Sermet-Gaudelus, MD,PhD Sub-Investigator: Michèle Gérardin Gérardin, MD Hôpital FOCH Recruiting Suresnes, France, 92150 Contact: Dominique Grenet, MD d.grenet@hopital-foch.org Principal Investigator: Dominique Grenet, MD CHU de Toulouse Recruiting Toulouse, France, 31000 Contact: Marlène Murris-Espin, MD murris.m@chu-toulouse.fr Contact: Murris-Espin Principal Investigator: Marlène Murris-Espin, MD Less << | |
NCT02516410 | Cystic Fibrosis | Phase 3 | Completed | - | - |
NCT01531673 | - | Completed | - | - | |
NCT02516410 | - | Completed | - | - | |
NCT02730208 | Cystic Fibrosis | Phase 2 | Completed | - | Australia ... More >> Chermside, Australia Melbourne, Australia Nedlands, Australia New Lambton Heights, Australia Parkville SIC, Australia Randwick, Australia South Brisbane, Australia Subiaco, Australia Westmead, Australia Less << |
NCT01931839 | Cystic Fibrosis, Homozygous or... More >> Heterozygous for the F508del-CFTR Mutation Less << | Phase 3 | Completed | - | - |
NCT00457821 | - | Completed | - | - | |
NCT02508207 | Cystic Fibrosis | Phase 2 | Completed | - | United States, Alabama ... More >> Birmingham, Alabama, United States United States, Indiana Indianapolis, Indiana, United States United States, Maryland Baltimore, Maryland, United States United States, North Carolina Chapel Hill, North Carolina, United States United States, Ohio Cincinnati, Ohio, United States Toledo, Ohio, United States United States, Pennsylvania Pittsburgh, Pennsylvania, United States Less << |
NCT00457821 | Cystic Fibrosis | Phase 2 | Completed | - | United States, Alabama ... More >> University of Alabama Hospital Birmingham, Alabama, United States, 35211 United States, California Stanford University Medical Center Palo Alto, California, United States, 34304 United States, Colorado The Children's Hospital Aurora, Colorado, United States, 80045 United States, Iowa Roy J. and Lucille A. Carver College of Medicine, The University of Iowa Iowa City, Iowa, United States, 52242-1083 United States, Maryland Johns Hopkins Hospital Baltimore, Maryland, United States, 21287 United States, Massachusetts Pulmonary and Critical Care Medicine, Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Children's Hospital of Boston Boston, Massachusetts, United States, 02215 United States, Minnesota Division of Pulmonary, Allergy and Critical Care Medicine, University of Minnesota Minneapolis, Minnesota, United States, 55455 United States, North Carolina Cystic Fibrosis Pulmonary Research and Treatment Center, University of North Carolina at Chapel Hill Chapel Hill, North Carolina, United States, 27599 United States, Ohio Rainbow Babies and Children's Hospital Cleveland, Ohio, United States, 44106 United States, Pennsylvania The Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States, 19104-4399 University of Pittsburgh Pittsburgh, Pennsylvania, United States, 15213 United States, Washington Pulmonary Critical Care, University of Washington Seattle, Washington, United States, 98195 Canada, Ontario Division of Gastroenterology, Hepatology and Nutrition, The Hospital for Sick Children Toronto, Ontario, Canada, M5G 1X8 Germany CF Clinic, Pediatric Pulmonology and Neonatology, Medical School of Hannover Strasse, Hannover, Germany, D-30625 Less << |
NCT02508207 | - | Completed | - | - | |
NCT02797132 | Cystic Fibrosis | Phase 3 | Completed | - | - |
NCT01931839 | - | Completed | - | - | |
NCT01807949 | Cystic Fibrosis, Homozygous fo... More >>r the F508del CFTR Mutation Less << | Phase 3 | Completed | - | - |
NCT01807923 | Cystic Fibrosis, Homozygous fo... More >>r the F508del CFTR Mutation Less << | Phase 3 | Completed | - | - |
NCT02953314 | Cystic Fibrosis | Phase 3 | Completed | - | - |
NCT02392234 | Cystic Fibrosis | Phase 3 | Completed | - | - |
NCT01888393 | Hepatic Impairment ... More >> Healthy Less << | Phase 1 | Completed | - | Czech Republic ... More >> Praha, Czech Republic Slovakia Bratislava, Slovakia Less << |
NCT01807949 | - | Completed | - | - | |
NCT00909727 | Cystic Fibrosis | Phase 3 | Completed | - | - |
NCT02514473 | - | Completed | - | - | |
NCT00909532 | Cystic Fibrosis | Phase 3 | Completed | - | - |
NCT02392234 | - | Completed | - | - | |
NCT00909532 | - | Completed | - | - | |
NCT01807923 | - | Completed | - | - | |
NCT01768663 | Cystic Fibrosis | Phase 1 | Completed | - | United States, Indiana ... More >> Evansville, Indiana, United States Less << |
NCT02514473 | Cystic Fibrosis | Phase 3 | Completed | - | - |
NCT01161537 | Cystic Fibrosis | Phase 2 | Completed | - | United States, Virginia ... More >> Charlottesville, Virginia, United States Less << |
NCT01117012 | Cystic Fibrosis | PHASE3 | COMPLETED | 2025-05-14 | Birmingham, Alabama, United St... More >>ates|Oakland, California, United States|Palo Alto, California, United States|San Diego, California, United States|Denver, Colorado, United States|Atlanta, Georgia, United States|Boise, Idaho, United States|Chicago, Illinois, United States|Indianapolis, Indiana, United States|Iowa City, Iowa, United States|Baltimore, Maryland, United States|Boston, Massachusetts, United States|Ann Arbor, Michigan, United States|Detroit, Michigan, United States|Minneapolis, Minnesota, United States|Kansas City, Missouri, United States|St. Louis, Missouri, United States|Omaha, Nebraska, United States|Long Branch, New Jersey, United States|Buffalo, New York, United States|New Hyde Park, New York, United States|Syracuse, New York, United States|Cincinnati, Ohio, United States|Cleveland, Ohio, United States|Columbus, Ohio, United States|Toledo, Ohio, United States|Portland, Oregon, United States|Hershey, Pennsylvania, United States|Philadelphia, Pennsylvania, United States|Pittsburgh, Pennsylvania, United States|Knoxville, Tennessee, United States|Nashville, Tennessee, United States|Salt Lake City, Utah, United States|Chrlottesville, Virginia, United States|Seattle, Washington, United States|Morgantown, West Virginia, United States|Westmead, New South Wales, Australia|Chermside, Queensland, Australia|Herston, Queensland, Australia|South Brisbane, Queensland, Australia|Parkville, Victoria, Australia|Nedlands, Western Australia, Australia|Subiaco, Western Australia, Australia|Vancouver, British Columbia, Canada|Halifax, Nova Scotia, Canada|Toronto, Ontario, Canada|Montreal, Quebec, Canada|Prague, Czech Republic|Paris, France|Roscoff, France|Erlangen, Germany|Jena, Germany|Munich, Germany|Wurzburg, Germany|Cork, Ireland|Dublin, Ireland|Belfast, Northern Ireland, United Kingdom|London, United Kingdom Less << |
NCT01161537 | - | Completed | - | - | |
NCT00909727 | - | Completed | - | - | |
NCT01117012 | Cystic Fibrosis | PHASE3 | COMPLETED | 2025-05-14 | Birmingham, Alabama, United St... More >>ates|Oakland, California, United States|Palo Alto, California, United States|San Diego, California, United States|Denver, Colorado, United States|Atlanta, Georgia, United States|Boise, Idaho, United States|Chicago, Illinois, United States|Indianapolis, Indiana, United States|Iowa City, Iowa, United States|Baltimore, Maryland, United States|Boston, Massachusetts, United States|Ann Arbor, Michigan, United States|Detroit, Michigan, United States|Minneapolis, Minnesota, United States|Kansas City, Missouri, United States|St. Louis, Missouri, United States|Omaha, Nebraska, United States|Long Branch, New Jersey, United States|Buffalo, New York, United States|New Hyde Park, New York, United States|Syracuse, New York, United States|Cincinnati, Ohio, United States|Cleveland, Ohio, United States|Columbus, Ohio, United States|Toledo, Ohio, United States|Portland, Oregon, United States|Hershey, Pennsylvania, United States|Philadelphia, Pennsylvania, United States|Pittsburgh, Pennsylvania, United States|Knoxville, Tennessee, United States|Nashville, Tennessee, United States|Salt Lake City, Utah, United States|Chrlottesville, Virginia, United States|Seattle, Washington, United States|Morgantown, West Virginia, United States|Westmead, New South Wales, Australia|Chermside, Queensland, Australia|Herston, Queensland, Australia|South Brisbane, Queensland, Australia|Parkville, Victoria, Australia|Nedlands, Western Australia, Australia|Subiaco, Western Australia, Australia|Vancouver, British Columbia, Canada|Halifax, Nova Scotia, Canada|Toronto, Ontario, Canada|Montreal, Quebec, Canada|Prague, Czech Republic|Paris, France|Roscoff, France|Erlangen, Germany|Jena, Germany|Munich, Germany|Wurzburg, Germany|Cork, Ireland|Dublin, Ireland|Belfast, Northern Ireland, United Kingdom|London, United Kingdom Less << |
NCT01937325 | Cystic Fibrosis | Phase 4 | Unknown | December 2016 | Australia, Victoria ... More >> The Alfred Melbourne, Victoria, Australia, 3004 Less << |
NCT00953706 | Cystic Fibrosis | Phase 2 | Terminated(Following review of... More >> results obtained from a pre-specified 6-month analysis of Part B data the study was terminated on the basis of futility.) Less << | - | - |
NCT02390219 | Cystic Fibrosis ... More >> Advanced Lung Disease Less << | Phase 3 | Completed | - | United States, Colorado ... More >> Denver, Colorado, United States United States, Florida Tampa, Florida, United States United States, Illinois Chicago, Illinois, United States United States, Missouri Saint Louis, Missouri, United States United States, Pennsylvania Pittsburgh, Pennsylvania, United States United States, Texas Houston, Texas, United States Less << |
NCT00953706 | - | Terminated(Following review of... More >> results obtained from a pre-specified 6-month analysis of Part B data the study was terminated on the basis of futility.) Less << | - | - | |
NCT02390219 | - | Completed | - | - | |
NCT01863238 | - | Completed | - | - | |
NCT03256799 | Cystic Fibrosis | Phase 4 | Completed | - | United States, Alabama ... More >> University of Alabama at Birmingham Birmingham, Alabama, United States, 35233 Less << |
NCT01685801 | Cystic Fibrosis | Phase 2 | Completed | - | United States, Colorado ... More >> Denver, Colorado, United States Less << |
NCT01685801 | - | Completed | - | - | |
NCT02823470 | Cystic Fibrosis | Phase 4 | Terminated(Study terminated ea... More >>rly due to slow recruitment of patients.) Less << | - | United States, Connecticut ... More >> Hartford, Connecticut, United States United States, District of Columbia Washington, District of Columbia, United States United States, Florida Orlando, Florida, United States United States, Georgia Atlanta, Georgia, United States United States, Mississippi Jackson, Mississippi, United States United States, New Mexico Albuquerque, New Mexico, United States United States, South Carolina Columbia, South Carolina, United States Canada, Alberta Edmonton, Alberta, Canada Canada, British Columbia Victoria, British Columbia, Canada Canada, New Brunswick Saint John, New Brunswick, Canada Canada Quebec, Canada Less << |
NCT02823470 | - | Terminated(Study terminated ea... More >>rly due to slow recruitment of patients.) Less << | - | - | |
NCT02015507 | Cystic Fibrosis | Phase 1 | Completed | - | - |
NCT02544451 | Cystic Fibrosis | Phase 3 | Active, not recruiting | November 2019 | - |
NCT01897233 | Cystic Fibrosis | Phase 3 | Completed | - | - |
NCT01897233 | - | Completed | - | - | |
NCT01899105 | Cystic Fibrosis | Phase 1 | Completed | - | United States, Florida ... More >> Daytona, Florida, United States Less << |
NCT02742519 | - | Terminated(Low enrollment.) | - | - | |
NCT01614470 | Cystic Fibrosis | Phase 3 | Completed | - | United States, Florida ... More >> Tampa, Florida, United States United States, Georgia Atlanta, Georgia, United States United States, Illinois Chicago, Illinois, United States United States, Massachusetts Boston, Massachusetts, United States United States, Michigan Ann Arbor, Michigan, United States United States, Minnesota Minneapolis, Minnesota, United States United States, Missouri St. Louis, Missouri, United States United States, Texas Houston, Texas, United States Belgium Leuven, Belgium France Lyon, France Montpellier, France Paris, France Less << |
NCT02653027 | Diabetes Cyst... More >>ic Fibrosis Less << | Not Applicable | Withdrawn(We couldn't find any... More >> eligible subjects for the study because most of the study population had already started on the combination therapy.) Less << | - | - |
NCT01614470 | - | Completed | - | - | |
NCT02742519 | Cystic Fibrosis | Phase 3 | Terminated(Low enrollment.) | - | Australia, Victoria ... More >> Parkville, Victoria, Australia Australia South Brisbane, Australia Subiaco, Australia Westmead, Australia Canada, Ontario Toronto, Ontario, Canada United Kingdom London, United Kingdom Less << |
NCT02412111 | Cystic Fibrosis | Phase 3 | Completed | - | - |
NCT02565914 | Cystic Fibrosis | Phase 3 | Enrolling by invitation | September 2019 | - |
NCT02858843 | Cystic Fibrosis ... More >> Diabetes Less << | Not Applicable | Terminated(We were unable to e... More >>nroll eligible subjects for the study.) Less << | - | - |
NCT03068312 | Cystic Fibrosis | Phase 3 | Active, not recruiting | December 2018 | Israel ... More >> Hadassah Medical Organization Jerusalem, Israel Less << |
NCT03512119 | - | Recruiting | October 10, 2018 | France ... More >> Hôpitaux Universitaires de Strasbourg Recruiting Strasbourg, Alsace, France, 67000 Contact: Laurence KESSLER Principal Investigator: Laurence KESSLER, MD Centre Hospitalier Universitaire d'Angers Recruiting Angers, France, 49033 Contact: Françoise TROUSSIER Principal Investigator: Françoise TROUSSIER Hôpital Renée Sabran Recruiting Giens, France, 83406 Contact: Laurent MELY Principal Investigator: Laurent MELY Centre Hospitalier Lyon Sud Recruiting Lyon, France, 69000 Contact: Isabelle DURIEU Principal Investigator: Isabelle DURIEU Hôpital NORD - Assistance Publique Hôpitaux de Marseille Recruiting Marseille, France, 13385 Contact: Bérengère COLTEY Principal Investigator: Bérengère COLTEY Hôpital Arnaud de Villeneuve Recruiting Montpellier, France, 34295 Contact: Raphael CHIRON Principal Investigator: Raphael CHIRON Hôpital Robert Debré Recruiting Paris, France, 75019 Contact: Michèle GERARDIN Principal Investigator: Michèle GERARDIN American Memorial Hospital Recruiting Reims, France, 51092 Contact: Michel ABLEY Principal Investigator: Michel ABELY Clinique "Mucoviscidose" Presqu'île de Perharidy Recruiting Roscoff, France, 29684 Contact: Gilles RAULT Principal Investigator: Gilles RAULT Hôpital Charles Nicolle Recruiting Rouen, France, 76031 Contact: Stéphane DOMINIQUE Principal Investigator: Stéphane DOMINIQUE Hôpital FOCH Recruiting Suresnes, France, 92151 Contact: Florence BOUILLOUD Principal Investigator: Florence BOUILLOUD Hôpital Bretonneau - CHRU de Tours Recruiting Tours, France, 37044 Contact: Julie MANKIKIAN Principal Investigator: Julie MANKIKIAN Hôpital de Clocheville - CHRU de Tours Recruiting Tours, France, 37044 Contact: Laure COSSON Principal Investigator: Laure COSSON Less << | |
NCT02310789 | - | Completed | - | - | |
NCT03251911 | Chronic Bronchitis | Phase 4 | Not yet recruiting | February 1, 2021 | United States, Alabama ... More >> University of Alabama at Birmingham Not yet recruiting Birmingham, Alabama, United States, 35233 Contact: Heather Hathorne, PhD 205-638-9568 hhathorne@peds.uab.edu Contact: Ginger Reeves, BS 205-638-5970 greeves@peds.uab.edu Less << |
NCT02807415 | - | Recruiting | June 2019 | Germany ... More >> Justus-Liebig-University Recruiting Gießen, Germany, 35385 Contact: Lutz Nährlich, MD 004964198557620 lutz.naehrlich@paediat.med.uni-giessen.de Contact: Claudia Rückes-Nilges, Dipl-Biol 004964198556945 claudia.rueckes-nilges@paediat.med.uni-giessen.de Principal Investigator: Lutz Nährlich, MD Sub-Investigator: Stefan Kuhnert, MD Hannover Medical School Recruiting Hannover, Germany, 30625 Contact: Burkhard Tümmler, MD PhD 00495115322920 tuemmler.burkhard@mh-hannover.de Contact: Christian Dopfer, MD 00495115326111 dopfer.christian@mh-hannover.de Principal Investigator: Burkhard Tümmler, MD PhD Sub-Investigator: Christian Dopfer, MD University of Heidelberg Recruiting Heidelberg, Germany, 69120 Contact: Marcus Mall, MD 00496221564502 Marcus.Mall@med.uni-heidelberg.de Contact: Simon Gräber, MD 004962215638926 Simon.Graeber@med.uni-heidelberg.de Principal Investigator: Marcus Mall, MD Sub-Investigator: Simon Gräber, MD Sub-Investigator: Susanne Dittrich, MD Less << | |
NCT01614457 | Cystic Fibrosis | Phase 3 | Completed | - | - |
NCT01946412 | Cystic Fibrosis | PHASE3 | COMPLETED | 2025-12-15 | Birmingham, Alabama, United St... More >>ates|Denver, Colorado, United States|Atlanta, Georgia, United States|Indianapolis, Indiana, United States|Boston, Massachusetts, United States|Grand Rapids, Michigan, United States|Minneapolis, Minnesota, United States|Kansas city, Missouri, United States|Omaha, Nebraska, United States|Salt Lake City, Utah, United States|Richmond, Virginia, United States|Seattle, Washington, United States|Vancouver, British Columbia, Canada|Edinburgh, United Kingdom|Liverpool, United Kingdom|London, United Kingdom Less << |
NCT01946412 | Cystic Fibrosis | PHASE3 | COMPLETED | 2025-12-15 | Birmingham, Alabama, United St... More >>ates|Denver, Colorado, United States|Atlanta, Georgia, United States|Indianapolis, Indiana, United States|Boston, Massachusetts, United States|Grand Rapids, Michigan, United States|Minneapolis, Minnesota, United States|Kansas city, Missouri, United States|Omaha, Nebraska, United States|Salt Lake City, Utah, United States|Richmond, Virginia, United States|Seattle, Washington, United States|Vancouver, British Columbia, Canada|Edinburgh, United Kingdom|Liverpool, United Kingdom|London, United Kingdom Less << |
NCT02725567 | Cystic Fibrosis | Phase 3 | Recruiting | June 2020 | - |
NCT02310789 | Cystic Fibrosis | Not Applicable | Completed | - | United States, California ... More >> Stanford Hospital and Clinics Stanford, California, United States, 94305 Less << |
NCT02934698 | Cystic Fibrosis | PHASE3 | COMPLETED | 2025-05-18 | - |
NCT02934698 | Cystic Fibrosis | PHASE3 | COMPLETED | 2025-05-18 | - |
NCT02135432 | Chronic Obstructive Pulmonary ... More >>Disease Less << | Early Phase 1 | Completed | - | United States, Alabama ... More >> University of Alabama at Birmingham Birmingham, Alabama, United States, 35233 Less << |
NCT03475381 | - | Active, not recruiting | June 30, 2018 | France ... More >> Adult CF center, Service de Pneumologie, Cochin Hospital Paris, France, 75006 Less << | |
NCT01614457 | - | Completed | - | - | |
NCT02135432 | - | Completed | - | - | |
NCT01707290 | Cystic Fibrosis | PHASE3 | COMPLETED | 2025-04-16 | Birmingham, Alabama, United St... More >>ates|Palo Alto, California, United States|Denver, Colorado, United States|Hartford, Connecticut, United States|Tampa, Florida, United States|Atlanta, Georgia, United States|Chicago, Illinois, United States|Iowa City, Iowa, United States|Lexington, Kentucky, United States|Baltimore, Maryland, United States|Boston, Massachusetts, United States|Ann Arbor, Michigan, United States|Detroit, Michigan, United States|Grand Rapids, Michigan, United States|Minneapolis, Minnesota, United States|St. Louis, Missouri, United States|Omaha, Nebraska, United States|New York, New York, United States|Syracuse, New York, United States|Valhalla, New York, United States|Chapel Hill, North Carolina, United States|Philadelphia, Pennsylvania, United States|Pittsburgh, Pennsylvania, United States|Charleston, South Carolina, United States|Nashville, Tennessee, United States|Dallas, Texas, United States|Fort Worth, Texas, United States|Houston, Texas, United States|Salt Lake City, Utah, United States|Richmond, Virginia, United States|Seattle, Washington, United States|Morgantown, West Virginia, United States|Madison, Wisconsin, United States|Leuven, Belgium|Montpellier, France|Paris, France|Belfast, United Kingdom|Edinburgh, United Kingdom Less << |
NCT01705145 | Cystic Fibrosis | PHASE3 | COMPLETED | 2025-03-14 | Birmingham, Alabama, United St... More >>ates|Aurora, Colorado, United States|Atlanta, Georgia, United States|Indianapolis, Indiana, United States|Lexington, Kentucky, United States|Boston, Massachusetts, United States|Detroit, Michigan, United States|Grand Rapids, Michigan, United States|Minneapolis, Minnesota, United States|Kansas City, Missouri, United States|Omaha, Nebraska, United States|Pittsburgh, Pennsylvania, United States|Salt Lake City, Utah, United States|Charlottesville, Virginia, United States|Richmond, Virginia, United States|Seattle, Washington, United States|Vancouver, Canada|Edinburgh, United Kingdom|Liverpool, United Kingdom|London, United Kingdom Less << |
NCT03439865 | Chronic Rhinosinusitis (Diagno... More >>sis) Less << | Early Phase 1 | Not yet recruiting | July 2022 | United States, Alabama ... More >> University of Alabama at Birmingham Not yet recruiting Birmingham, Alabama, United States, 35233 Contact: Lisa Clemons, MSN, RN 205-934-9714 lkclemons@uabmc.edu Principal Investigator: Brad Woodworth, MD Less << |
NCT01784419 | Cystic Fibrosis | Not Applicable | Unknown | December 2015 | United States, California ... More >> University of California, San Francisco Recruiting San Francisco, California, United States, 94143 Contact: Dennis Nielson, MD, PhD 415-476-2072 nielsond@peds.ucsf.edu Contact: Dennis W Nielson, MD. PhD 415-476-2072 nielsond@peds.ucsf.edu Principal Investigator: Dennis W Nielson, MD, PhD Sub-Investigator: Meghan McGarry, MD Sub-Investigator: Ngoc Ly, MD, MPH Sub-Investigator: Mary Ellen Kleinhenz, MD Less << |
NCT02194881 | - | Completed | - | France ... More >> Hôpital Cochin Paris, France, 75014 Less << | |
NCT01707290 | Cystic Fibrosis | PHASE3 | COMPLETED | 2025-04-16 | Birmingham, Alabama, United St... More >>ates|Palo Alto, California, United States|Denver, Colorado, United States|Hartford, Connecticut, United States|Tampa, Florida, United States|Atlanta, Georgia, United States|Chicago, Illinois, United States|Iowa City, Iowa, United States|Lexington, Kentucky, United States|Baltimore, Maryland, United States|Boston, Massachusetts, United States|Ann Arbor, Michigan, United States|Detroit, Michigan, United States|Grand Rapids, Michigan, United States|Minneapolis, Minnesota, United States|St. Louis, Missouri, United States|Omaha, Nebraska, United States|New York, New York, United States|Syracuse, New York, United States|Valhalla, New York, United States|Chapel Hill, North Carolina, United States|Philadelphia, Pennsylvania, United States|Pittsburgh, Pennsylvania, United States|Charleston, South Carolina, United States|Nashville, Tennessee, United States|Dallas, Texas, United States|Fort Worth, Texas, United States|Houston, Texas, United States|Salt Lake City, Utah, United States|Richmond, Virginia, United States|Seattle, Washington, United States|Morgantown, West Virginia, United States|Madison, Wisconsin, United States|Leuven, Belgium|Montpellier, France|Paris, France|Belfast, United Kingdom|Edinburgh, United Kingdom Less << |
NCT03085485 | Chronic Obstructive Pulmonary ... More >>Disease Chronic Bronchitis Less << | Phase 2 | Recruiting | April 2019 | United States, Alabama ... More >> UAB Lung Health Center Recruiting Birmingham, Alabama, United States, 35294 Contact: Mark T Dransfield, MD 205-934-5555 Principal Investigator: Mark T Dransfield, MD Less << |
NCT01705145 | Cystic Fibrosis | PHASE3 | COMPLETED | 2025-03-14 | Birmingham, Alabama, United St... More >>ates|Aurora, Colorado, United States|Atlanta, Georgia, United States|Indianapolis, Indiana, United States|Lexington, Kentucky, United States|Boston, Massachusetts, United States|Detroit, Michigan, United States|Grand Rapids, Michigan, United States|Minneapolis, Minnesota, United States|Kansas City, Missouri, United States|Omaha, Nebraska, United States|Pittsburgh, Pennsylvania, United States|Salt Lake City, Utah, United States|Charlottesville, Virginia, United States|Richmond, Virginia, United States|Seattle, Washington, United States|Vancouver, Canada|Edinburgh, United Kingdom|Liverpool, United Kingdom|London, United Kingdom Less << |
NCT03277196 | Cystic Fibrosis | Phase 3 | Recruiting | June 7, 2021 | - |
NCT03783286 | Cystic Fibrosis | COMPLETED | 2021-12-30 | Children's Hospital of Philade... More >>lphia, Philadelphia, Pennsylvania, 19146, United States Less << | |
NCT04066751 | Chronic Obstructive Pulmonary ... More >>Disease Less << | PHASE2 | WITHDRAWN | 2024-10-31 | - |
Bio Calculators | ||||
Preparing Stock Solutions | ![]() |
1mg | 5mg | 10mg |
1 mM 5 mM 10 mM |
2.55mL 0.51mL 0.25mL |
12.74mL 2.55mL 1.27mL |
25.48mL 5.10mL 2.55mL |
|
Dissolving Methods |
in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day; The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound. Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:
|